Dr. Sokolov has experience across all aspects of the US healthcare industry, with expertise in healthcare delivery, biotechnology, and regulatory clearance. Dr. Sokolov was appointed Chair of the Artrya Clinical Advisory Board in January 2022 and became Chairman and President of Artrya USA Inc. in March 2022. He is also Chairman and Chief Executive Officer of SSB Solutions, Inc, a diversified US healthcare management, development, and financial services company that has partnered with more than 100 healthcare organisations across multiple sectors. In addition, Dr. Sokolov currently serves on several public, private, and not-for-profit healthcare boards, with a particular focus on advanced digital health technologies and next-generation genetics-based companies. Over the past three years, he has served as a director of Lucid Diagnostics, Inc. where he is Chairman of the Compliance & Quality Committee and a member of the Audit and Compensation Committees. Previously, he served on the board of MedCath Corporation, where he chaired the Compliance/Quality Committee.
